Pik3ca, braf, nras and kras mutations and outcome prediction in chemorefractory metastatic colorectal cancer (mcrc) patients treated with egfr-targeting monoclonal antibodies (moabs): results of a european consortium
2010
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
7
Citations
NaN
KQI